INS and Anorexia: The decrease in insulin injections per se, as well as the advantage of the non-activity of DPP4-i molecules at low–normal glycemic levels, provides comfortability and safety in old and frail patients who may be unable to complete their intake of a given hospital meal due to increased anorexia or inappetence for hospital food.